Our mission is to make a difference in the lives of patients through the development and supply of innovative products and medicines throughout the world.
Aspire Pharma is a life sciences business, based in the UK, devoted to delivering true value to patients, healthcare professionals and the NHS.
To create a business, which could be agile to opportunity, unconstrained by market segment, and whose products could make a valuable difference to patients and payors.
Aspire’s founding principle was to take a medicine, a molecule or a device and enhance it. This might be an improved presentation, a more convenient dose, or a more acceptable formulation for patients, and that principle still drives everything we do today
Our therapy areas cover:
We have a dedicated, smart, high energy team, who have a reputation for making it happen.
We have deep knowledge of the UK healthcare system; and the relationships we have developed with government agencies, such as the MHRA, NICE, The Department of Health and many more has led to a track record in timely marketing authorisation approvals, competitive pricing and effective market access strategies.
Our national team promotes, consults and provides solutions for health care professionals who prescribe our hospital initiated medicines.
We have a national team who promote our Over the Counter (OTC) and consumer health portfolios within UK pharmacies.
We work with wholesalers and pharmacy groups to ensure best value with our generic range.
A proven ability to market and supply medicines, drawing on experience of 100s of product launches within the world’s leading life science businesses.
A robust pipeline and active business development endeavours ensure continued business growth, for the benefit of current and future patients.
Consistently delivering on promises to both partners and customers, with market leading brands that patients rely on.
A supply chain that delivers, with stock and price guarantees to ensure consistency and reliability.
Continuing to satisfy unmet customer needs through product differentiation and unique IP development.